Athletics News |
Dr. Santa Ono
Santa Jeremy Ono, PhD, is the 28th President at the University of Cincinnati. After serving on an interim basis for two months, he was appointed to the presidency on Oct. 23, 2012.
President Ono first arrived at UC in 2010, serving two years as the Senior Vice President for Academic Affairs and Provost. As Provost, he led the development of an Academic Master Plan (AMP) aligned to the university's strategic plan, UC2019► - Accelerating Our Transformation. The AMP, unveiled in May 2012, will mean aninitial investment of about $10 million toward long-term strategic goals set for completion in UC's bicentennial year, 2019.
Dr. Ono is the first Asian-American to serve as UC's chief executive and one of only a few Asian-Americans to serve as president of a major research institution in the United States.
Dr. Ono also serves as Professor of Pediatricswithin UC's College of Medicine and Professor of Biology in the McMicken College of Arts and Sciences. Dr. Ono's principal research interests focus on transcriptional regulation in the human immune system, mechanisms of mast cell dependent inflammation on the ocular surface and the immune component of age-related macular degeneration.
Prior to UC, Dr. Ono served at Emory University asVice Provost for Academic Initiatives and Deputy to theProvost and then Senior Vice Provost for Undergraduate Academic Affairs. He also served as Professor in the Department of Ophthalmology, Emory University School of Medicine.
Dr. Ono's first academic appointment was at the Johns Hopkins School of Medicine. While at Johns Hopkins, he won the American Diabetes Association Career Development Award and the Investigator Award from the National Arthritis Foundation.
In 1996, Dr. Ono was recruited to the Harvard Medical School, where he was an Associate Professor and on staff at the Schepens Eye Research Institute. He was a member of the Executive Committee of the Harvard Program in Immunology and a principal investigator of the Harvard Program in Ocular Immunology. He also served on the Executive Committee of the NIH Training Program in Molecular Bases of Eye Diseases.
Following his Harvard appointments, Dr. Ono served as Cumberlege Professor and GlaxoSmithKline Chair of Biomedical Sciences at University College London (UCL) and Moorfields Eye Hospital; head of the Department of Immunology at the UCL Institute of Ophthalmology; on the executive committee of the UCL Division of Infection and Immunity; and as Associate Dean of Students, a member of the UCL Council (the university's governing body) and its finance committee.
Dr. Ono's service outside of the university includes the Boards of Directors of the Cincinnati Symphony Orchestra, the Japan-America-Society and the Alois Alzheimer's Society. He chairs the board of the Global H.E.E.D (Promoting Health, Education and Economic Development) and co-chairs the Cincinnati/Northern Kentucky Early Grade-Level Reading Campaign. He is a member of the Chancellor's Ohio Completion Task Force of the Ohio Board of Regents as well as the Executive Committee of the STRIVE partnership and served on the Board of Advisors for Strive for College.
He has served on the Medical Research Council's Medical Advisory Board and College of Experts and the IMS and HAI study sections of the NIH. He consults widely for companies such as GSK, Cambridge Antibody Technologies plc (now part of Astra Zeneca), Johnson & Johnson, Santen Inc. and Oxagen plc. He is chief scientific officer of iCo Therapeutics Inc., of Vancouver, Canada.
As a scholar and researcher, Dr. Ono has served on the editorial boards of the Journal of Immunology, Journal of Biological Chemistry, Immunology and the Journal of Allergy & Clinical Immunology.
Among his many honors are the Brit Katz Award from Emory University,the Roche Laboratories Award for Excellence in Research, the Pharmacia International Award in Allergy Research and the Medal in Bronze from Osaka City University.
Dr. Ono earned his PhD at McGill University and his BA at the University of Chicago. His training in Biochemistry and Molecular Biology at Harvard was supported by a Helen Hay Whitney Foundation Fellowship.
Dr. Ono is also a huge supporter of Bearcats Athletics and can often be seen interacting with the student body and fans at games.